Marit Westerterp

7.6k citations

77 papers · 5.1k indexed · 2 hit papers · h-index 40

Impact in

Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases
- Immune cells in cancer
Cancer Research top 2%
- Cancer, Lipids, and Metabolism

Papers in

Immunology 26
- Atherosclerosis and Cardiovascular Diseases 14
Surgery 45
- Cholesterol and Lipid Metabolism 35
- Lipoproteins and Cardiovascular Health 13

Co-authors: Alan R. Tall Andrew Murphy Laurent Yvan‐Charvet Nan Wang Sandra Abramowicz Patrick C.N. Rensen Louis M. Havekes Carrie L. Welch
Journals: Arteriosclerosis Thrombosis and Vascular Biology (11 papers)Journal of Lipid Research (9 papers)Circulation Research (8 papers)Atherosclerosis (6 papers)Circulation (5 papers)
Partner nations: Netherlands United States France

In The Last Decade

Marit Westerterp

76 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research 2021 · 198 citations

Peers

Countries citing papers authored by Marit Westerterp

Since Specialization

Citations

This map shows the geographic impact of Marit Westerterp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Westerterp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Westerterp more than expected).

Fields of papers citing papers by Marit Westerterp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit Westerterp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Westerterp. The network helps show where Marit Westerterp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marit Westerterp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marit Westerterp Line = papers co-authored together Marit Westerterp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis Journal of Lipid Research ·Mustafa Yalçınkaya, Wenli Liu, Tong Xiao, Sandra Abramowicz, Ranran Wang, Nan Wang, Marit Westerterp, Alan R. Tall	2024	13
2	Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice Prostaglandins Leukotrienes and Essential Fatty Acids ·Francesca Marcucci, N. Rehbinder, Ramon Bossardi Ramos, Sudeshna Sadhu, Saran Kumar K, Gabrielle Fredman, Marit Westerterp	2024	1
3	Apolipoprotein(a) production and clearance are associated with plasma IL-6 and IL-18 levels, dependent on ethnicity Atherosclerosis ·Francesca Marcucci, Miodrag Mladenovic, J. J. Green, Emmanuel Dumbuya, Hanrui Zhang, Marit Westerterp, Gissette Reyes‐Soffer	2024	4
4	Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat EJNMMI Research ·Jürgen W. A. Sijbesma, Aren van Waarde, E. Owen, A. O. Koptyukhov, Uwe J.F. Tietge, Jan‐Luuk Hillebrands, Marian Bulthuis, Hendrik Buikema, B. Lee, Marit Westerterp, Fan Liu, Hendrikus H. Boersma, Rudi Dierckx, Riemer H. J. A. Slart	2023	3
5	BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis Circulation ·Mustafa Yalçınkaya, Wenli Liu, Raymond Chabaud, Malgorzata Olszewska, Tong Xiao, Sandra Abramowicz, Eirini P. Papapetrou, Marit Westerterp, Nan Wang, Ira Tabas, Alan R. Tall	2023	42
6	Circadian rhythm parameters and physical activity associated with cardiometabolic risk factors in the PREVIEW lifestyle study Obesity ·Margriet S. Westerterp‐Plantenga, Mathijs Drummen, Beatriz Marques Ribeiro Veloso, 国男船橋, Gareth Stratton, Anne Raben, Marit Westerterp, Tanja C. Adam	2023	3
7	Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based LifeLines DEEP cohort Atherosclerosis ·Francesca Marcucci, Saran Kumar K, Isabelle A. van Zeventer, Lianmin Chen, Hilde E. Groot, BerndFleishmann, Alexandra Zhernakova, Pim van der Harst, Antoine Rimbert, Jan Albert Kuivenhoven, Jingyuan Fu, Marit Westerterp	2022	3
8	Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion Cardiovascular Research ·Mustafa Yalçınkaya, Panagiotis Fotakis, Wenli Liu, Kaori Endo‐Umeda, Huijuan Dou, Sandra Abramowicz, Tong Xiao, Peter Libby, Nan Wang, Alan R. Tall, Marit Westerterp	2022	54
9	Increased atherosclerosis in a mouse model of glycogen storage disease type 1a Molecular Genetics and Metabolism Reports ·Luma Amer, Francesca Marcucci, Emmanuel Dumbuya, Saran Kumar K, Ippei Enokida, Rohini Uma-Vaideswaran, Mirjam H. Koster, Niels Kloosterhuis, Marieke Smit, Rick Havinga, Gilles Mithieux, Fabienne Rajas, Folkert Kuipers, Maaike H. Oosterveer, Marit Westerterp	2022	1
10	Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation Pulmonary Circulation ·Pablo Fernández Alonso, Quint A. J. Hagdorn, Saran Kumar K, Johannes M. Douwes, Diederik E. van der Feen, Silke U. Oberdorf‐Maass, Marit Westerterp, Rolf M.F. Berger	2022	14
11	HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research Circulation ·Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, Alan T. Remaley, Kerry‐Anne Rye Hit paper breakdown →	2021	198
12	Myeloid cells regulate plasma LDL-cholesterol levels Current Opinion in Lipidology ·Saran Kumar K, Luma Amer, Marit Westerterp	2018	4
13	TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis Nature ·Joanne Hsieh, Masahiro Koseki, Matthew M. Molusky, Emi Yakushiji, Ikuyo Ichi, Marit Westerterp, Jahangir Iqbal, Robin Chan, Sandra Abramowicz, Xiang Yuan, Shunichi Takiguchi, Shizuya Yamashita, Carrie L. Welch, Gilbert Di Paolo, M. Mahmood Hussain, Jay H. Lefkowitch, Daniel J. Rader, Alan R. Tall	2016	69
14	Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice Journal of Clinical Investigation ·Catherine Martel, Wenjun Li, Brian Fulp, Andrew M. Platt, Emmanuel L. Gautier, Marit Westerterp, Robert Bittman, Alan R. Tall, Shu‐Hsia Chen, Michael J. Thomas, Daniel Kreisel, Melody A. Swartz, Mary G. Sorci‐Thomas, Gwendalyn J. Randolph	2013	255
15	Regulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways Cell stem cell ·Marit Westerterp, Samuel Gourion‐Arsiquaud, Andrew Murphy, Alan H. Shih, Serge Cremers, Ross L. Levine, Alan R. Tall, Laurent Yvan‐Charvet	2012	211
16	Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix Journal of Lipid Research ·Jimmy F.P. Berbée, Claudia P. Coomans, Marit Westerterp, Johannes A. Romijn, Louis M. Havekes, Patrick C.N. Rensen	2010	30
17	Ritonavir protects against the development of atherosclerosis in APOE3-Leiden mice Atherosclerosis* ·Marion A.M. den Boer, Marit Westerterp, Jitske de Vries-van der Weij, Yanan Wang, Lihui Hu, 黄忠顺, Teake Kooistra, Peter Reiss, Johannes A. Romijn, Louis M. Havekes, Patrick C.N. Rensen	2009	3
18	Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE3-Leiden.CETP mice Atherosclerosis* ·Willeke de Haan, Caroline C. van der Hoogt, Marit Westerterp, Menno Hoekstra, Geesje M. Dallinga‐Thie, P. Hans, Johannes A. Romijn, J. Wouter Jukema, Louis M. Havekes, Patrick C.N. Rensen	2007	70
19	Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages Atherosclerosis ·Marit Westerterp, Miranda Van Eck, Willeke de Haan, Erik H. Offerman, Theo J.C. van Berkel, Louis M. Havekes, Patrick C.N. Rensen	2007	27
20	Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL Journal of Lipid Research ·Marit Westerterp, Willeke de Haan, Valentina Atenas, Louis M. Havekes, Patrick C.N. Rensen	2006	46

About Marit Westerterp

Marit Westerterp is a scholar working on Immunology, Surgery, Hematology, Cancer Research and Oncology, having authored 77 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (35 papers), Peroxisome Proliferator-Activated Receptors (15 papers), Atherosclerosis and Cardiovascular Diseases (14 papers), Lipoproteins and Cardiovascular Health (13 papers), Drug Transport and Resistance Mechanisms (12 papers), Cancer, Lipids, and Metabolism (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Inflammasome and immune disorders (7 papers). The work is most often cited by research in Immunology (1.7k citations), Cancer Research (717 citations), Endocrinology, Diabetes and Metabolism (774 citations), Surgery (1.8k citations) and Cardiology and Cardiovascular Medicine (641 citations). Marit Westerterp has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Alan R. Tall, Andrew Murphy, Laurent Yvan‐Charvet, Nan Wang, Sandra Abramowicz, Patrick C.N. Rensen, Louis M. Havekes, Carrie L. Welch, Andrea E. Bochem and Panagiotis Fotakis. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research, Circulation Research, Atherosclerosis and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact